The Role of Cytokines in Physiological and
Pathological Conditions
Huri-Hadad Y., Soskolne A., Halabi A., Barak V., Shapira L. (2000) Repeat bacterial cheallenge in a subcutaneous chamber model: Results in augmented TNF and IFN response and supression of IL-10. Immunology, 99:215-220.
Abramov D., Erez E., Dagan O., Katz J., Vidne BA., Barak V. (2000) Increased levels of basic fibroblast growth factor are found in the cross-clamped heart during cardiopulmonar bypass. Cancer Journal Cardiol., 16(2):175-180.
Kori M., Barak V., Leibovitz E., Altman Y., Eliraz A., Handzel Z.T. (2000) Specific in vitro proliferative immune response and lymphokine production in ethiopian chlidren with and without tuberculosis.Infection, 28(1):42-45.
Nagler R., Barak V., Nagler A. (2000) Short term systemic effects of head and neck irradiation. Anticancer research, 20:1865-1870.
Aizman I., Many A., Rosenthal E., Schiby G., Goldberg I., Barak V., Ramot B., Kaufman Y. (2000) Neoplastic cell activation and proliverative response to CD40-Ligand characterize recurrent leucemic bouts in an unusual case of Low Grade Lymphoma. Leukemia and Lymphoma, 36(5-6):613-623.
Israel Z., Lossos A., Barak V., Soffer D., Siegal T. (2000) Multifocal demyelinative leukoencephalopathy associated with 5-FU and levamisole. Acta Oncology 39:117-120.
Pizov R., Weiss Y., Oppenheim-Eden A., Glickman H., Goodman S., Koganov Y., Barak V., Merin G., Kramer R. High oxygen concentration exacerbates cardiopulmonary bypass-induced lung injury. Cardiothoracic and Vascular Anesthesia. 14:514-519.
Abramov Y., Anteby S.O., Fasouliotis S.J., Barak V. (2001) The role of Leptin and its kinetics in Meig’s syndrome. Gynecolgical Oncology 83:316-318.
Abramov Y., Schenker J.G., Levin A., Kafka I., Jaffe H., Barak V. (2001) The role of plasma Adhesive molecules (ELAM +ICAM) and biological aspects of ovarian hyperstimulation syndrome (OHSS). Fertil. And Steril. 76:51-57.
Condiotti R., Bar Zakai Y., Barak V., Nagler A.(2001) In vivo expansion of CD56 cytotxic cells from human umbilical cord blood. Exp. Hematology 29:104-113.
Barak V., Halperin T., Kalickman I. (2001) The effects of Sambucol products on cytokines production: I. Inflammatory cytokines. Eur. Cytokine Network. 12(2):290-296.
Ben-Ishay Z., Barak V.. (2001) Possible cause of Bone Marrow stromal damage in mice administered cytosine arabinoside. Eur. J. Haematology. 66:230-237.
Abramov D., Erez E., Tamariz M., Dagan O., Pearl E., Abramov Y., Gendel B., Desai N., Katz J., Vidne B., Barak V (2002) Plasma Vascular Endothelial Growth Factor (VEGF) is a predictor of the severity of postoperative capillary leak syndrom in neonates undergoing cardiopulmonary bypass. Pediatric Surg. Int. 18:54-59.
Abramov Y., Anteby S.O., Fasouliotis S.J., Barak V. (2002) The role of inflammatory cytokines in Meig’s syndrome. Obstet and Gynecol. 99:917-919.
Tumor Markers
Barak V. (2000) Cytokeratins as tumor markers. Journal Tumor Marker Oncology. 15(3):3-4.
Nisman B., Heching N., Barak V. (2000) Serum tumor markers in resectable and non-resectable non-small cell lung cancer. Journal Tumor Marker Oncology. 15(3):11-23.
Barak V., Nisman B., Hubert A., Lyass O., Kadouri L., Peretz T. (2000) Prognostic efficacy of TPS in breast cancer. Journal Tumor Marker Oncology. 15(3):4-10.
Einarsson R., Barak V. (2000) TPS; A Cytokeratin serum Tumor Marker for effective therapy control of cancer patients with focus on breast cancer. Journal Clinical Ligand Assay. 22(4):348-352.
Gavish Z., Pinthus J., Barak V., Ramon J., Nagler A., Eshhar Z., Pines M. (2002) Growth inhibition of prostate cancer xenografts by Halofuginone. The Prostate. 51:73-83.
Tumor invasion and metastasis:
Signal Transduction
Landau E., Tirosh R., Pinson A., Banai S., Even-Ram S., Maoz M., Katzav, S., Bar-Shavit R. (2000), Protection of thrombin receptor expression under hypoxia. J Biol Chem 275: 2281-2287.
Even-Ram Cohen S., Maoz M., Pokroy E., Reich R., Katz BZ., Gutwein P., Altevogt P.,
Bar-Shavit, R. (2001). Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin. J Biol Chem. Apr 6;276(14):10952-62.
Schiffenbauer Y.S., Meir G., Maoz M., Even - Ram Cohen S., Bar-Shavit, R., Neeman M., (2002), Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and Cv integrin. Gynecologic Oncology, Feb, 84(2): 296-302.
Bar-Shavit R., Maoz M., Yin Y.J., Groysman M., Dekel I., and Katzav K., ( 2002) Dissection of signaling pathways induced by Protease Activated Receptors in T cells. Immunology Jan 105(1): 35-46.
Cancer Metastasis and Angiogenesis
Friedmann Y., Vlodavsky I., Aviv A., Peretz T., Pecker I., Pappo O.( . 2000). Expression of heparanase in normal, dysplastic and neoplastic human colonic mucosa. Am. J. Pathol. 157: 1167-1175.
Elkin M., H-Q. Miao A., Nagler E., Aingorn R., Reich I., Hemo H-L., Dou M.,Pines I., Vlodavsky.( 2000) Halofuginone: a potent inhibitor of critical steps in angiogenesis progression. FASEB J. 14: 2477-2485.
Bentolila A., Vlodavsky I., Ishai-Michaeli R., Kovalchuk O., Haloun C., Domb A.J., (2000), Poly(n-acryl amino acids) - a new class of biologically active polyanions. J. Med. Chem. 43: 2591-2600.
Grisaru D., Vlodavsky I., Aingorn H., Levavi H., Eldor A., Lessing J.B., Pruss D. Friedmann Y. (2000), Connective tissue activating peptide III (CTAP-III) expression disappears in correlation with dysplasia in himan cervical epithelium. Gynecol. Oncol. 79: 23-27.
Deutsch V., Bitan M., Friedmann Y., Eldor A., Vlodavsky I.( 2000), Megakaryocyte maturation Is associated with expression of the CXC chemokine connective tissue activating peptide III (CTAP-III). British J. Haematol. 111: 1180-1189.
Benezra M., Vogel T., Ben-Sasson S., Panet A., Sehayek E., Eisenberg S.,Vlodavsky I. ( 2001) A synthetic heparin-mimicking polyanionic compound binds to the LDL receptor-related protein and inhibits vascular smooth muscle cell proliferation. J. Cell. Biochem. 81: 114-127.
Vlodavsky I., Friedmann Y. (2001) Molecular Properities and involvement of heparanase in cancer metasasis and angiogenesis. J. Clin. Invest. 108:341-347.
Zcharia E., Metzger S., Friedmann Y., Pappo O., Aviv A., Elkin E., Pecker I., Peretz T., Vlodavsky I. (2001). Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis. Mammary Gland Biology & Neoplasm. 6:311-322.
Neuger L., Ruge T., Makoveichuk E., Vlodavsky I., Olivecrona G.(2001) Effects of the heparin-mimicking compound RG-13577 on lipoprotein lipase and on lipase binding of LDL to cells. Atherosclerosis, 157: 13-21
Ginath S., Menczer J., Friedmann Y., Aingorn H., Aviv A., Tajima K.., Dantes A., Glezerman M., Vlodavsky I., and Amsredam A. (2001), Expression of heparanase, Mdm2, and erbB2 in ovarian cancer. Int. J. Oncol. 18: 1133-1144 .
Elkin M., Ishai-Michaeli R., Friedmann Y., Papo O., Pecker I., Vlodavsky I.( 2001), Heparanase as mediator of angiogenesis: mode of action. FASEB J. 15: 1661-1663.
Goldshmidt O., Zcharia E., Aingorn H., Guatta-Rangini Z., Atzmon R., Michal I. Pecker I., Mitrani E., Vlodavsky I.( 2001) Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence. J. Biol. Chem. 276: 29178-29187.
Koliopanos A., Friess H., Kleeff J., Shi X., Liao Q., Pecker I., Vlodavsky I., Zimmermann M. Büchler W. (2001), Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res. 61: 4655-4659.
Vlodavsky I., Goldshmidt O., Zcharia E., Atzmon R., Peretz P., Elkin M., Friedmann Y. (2002) Mammalian Heparanase: Involvement of Heparanase in cancer Metastasis, angiogenesis and normal development. Seminars Cell Biol. 12:121-129.
Vlodavsky I., Goldshmidt O., Zcharia E., Metzger S., Peretz T., Pecker I. Friedmann Y. (2001) Molecular properties and involvement of heparanase in cancer progression and normal development. Biochemie 83:831-839.
Bitan M., Polliack A., Zecchina G., Nagler A., Friedmann Y., Nadav L., Deutsch V., Pecker I., Eldor A., Vlodavsky I., Katz B.Z. (2002) Heparanase Expression in human leukemias is restricted to aml. Exp. Hematol 30:34-41.
Haimov-Kochman R., Friedmann Y., Prus D., Goldman-Wohl D., Greenfield C., Anteby E., Aviv A., Vlodavsky I., Yagel S. (2002). Localization of heparanase in normal and pathological human placenta. Mol. Human Reproduction. 8: 566-573
Nadav L., Yacoby-Zeevi O., Zamir E., Pecker I., Ilan N., Geiger B., Eldor A., Vlodavsky I. Katz B.Z. (2002). Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts. J. Cell Sci. 115: 2179-2187.
Schmidt A., Vlodavsky I., Volker W., Sindermann J. R., and Buddecke E. (2002), Induction of a hypertrophic growth status of coronary smooth muscle . Eur. J. Cell Biol. 81:bcells is associated with overexpression of TGF 138-144.
Goldshmidt O., Zcharia E., Vlodavsky, I. (2002). Involvement of heparanase in cancer metastasis and angiogenesis. Directions in Science, 1: 73-76.
Goldshmidt O., Zcharia E., Abramovitch R., Metzger S., Guatta-Rangini Z., Aingorn H., Friedmann Y., Mitrani E., Vlodavsky I. (2002) Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. PNAS. (In press)
Shargal Y., Viola N., Nagler A., Merin G., Schmidt A., Buddecke E., Ben-Sasson S.A Vlodavsky, I., Inhibition of anastomotic intimal hyperplasia by a synthetic non-sulfated heparin-mimicking compound. Expt. Clin. Cardiol. (In press).
Benezra M., Ishai-Michaeli R., Ben-Sasson R., Vlodavsky I., Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity. J. Cell. Physiol. (In press).
Melanoma Immunotherapy
Klein M., Freedman N., Lotem M., Marciano R., Moshe S., Gimon Z., Chisin R.:( 2000) Contribution of whole body 18FDG-PET and lymphoscintigraphy to the assessment of regional and distant metastases in cutaneous malignant melanoma: a pilot study. Nuklearmedizin 39:56-61.
Yakobson E., Shemesh P., Azizi E., Winkler E., Lassam N., Hogg D., Brookes S., Peters G., Lotem M., Zlotogorsky A., Landau M., Safro M., Shafir R., Friedman E., Peretz H. (2000)
Two p16(CDKN2A) germline mutations in 30 Israeli melanoma families. Eur J Hum Genet 8:590-6.
Lotem M., Hubert A., Lyass A., Goldenhersh M., Ingber A., Peretz T., Gabizon A., (2000) Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin. Arch Dermatol 136:1475-1480.
Lotem M., Raben M., Zeltser R., Landau M., Sela M., Wigoda M., Tochner Z. (2001)
Kindler syndrome complicated by squamous cell carcinoma of the hard palate. Successful treatment with high dose radiation therapy and Ggranulocyte-Macrophage Colony Stimulating Factor. (correspondence) Br J Dermatol 144: 1-3.
Pappo I., Lotem M., Klein M., Orda R. ( 2001) Bolus high dose interleukin-2 for the treatment of malignant melanoma. Isr Med Assoc J 2001:169-73
Lotem M., Peretz T., Drize O., Gimon Z., Ad EL D., Weitzen R., Goldberg H., Ben David I., Prus D., Hamburger T., Shiloni E.: (2002) Autologous cell vaccine as a postoperative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). Br J Cancer. 86:1534-9.
Markel G., Lieberman N., Katz G., Arnon T.I., Lotem M., Drize O., Blumberg R.S., Bar-Haim E., Mader R., Eisenbach L., Mandelboim O. (2002) CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity. J Immunol. 168:2803-10.
Hazzan D., Reissmann P., Halak M., Resnick M.B., Lotem M., Shiloni E. (2001). Primary rectal malignant melanoma: report of two cases. Tech Coloproctol. Apr;5(1):51-4.
Hochberg M., Lotem M., Gimon Z., Shiloni E., Enk C.D. (2002) Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma. Br J Dermatol 146: 244-249.
Lotem M., Antebi S., Peretz T., Ingber A., Prus D.(2002) Mucosal melanoma of the female genitalia is a multifocal disorder of the entire squamous perineal epithelium Gynecol Oncol (accepted pending revision, June)
Breast Cancer and Genetics
of Breast Cancer
Wang T., Lerer I., Gueta Z., Sagi M., Kadouri L., Peretz T., Abeliovich D. (2001)ׂA deletion/insertion mutation in the BRCA1/2 gene in a breast cancer family: A possible role of the Alu-polyA tail in the evolution of the deletion genes. Genes, Chromosomes and Cancer, 31: 91-95.
Kadouri L., Easton D.F., Edwards S., Hubert A., Kote-Jarai Z., Glaser B., Durocher F., Abeliovich D., Peretz T., Eeles R.A. (2001).CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers. British Journal of Cancer Research. 85: (1), 36-40.
Manning A.P., Abeliovich D., Ghadirian P., Lambert J.A., Frappier D., Provencher D., Robidoux A., Peretz T., Narod S.A., Mes-Masson A.M., Foulkes W.D., Wang T., Morgan K., Fujiwara T.M., Tonin P.N. (2001). Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families. Hum Hered. 52: (2), 116-120.
Thompson D., Szabo C.I., Mangion J., Oldenburg R.A., Odefrey F., Seal S., Barfoot R., Kroeze-Jansema K., Teare D., Rahman N., Renard H., KConFab Consortium, Mann G., Hopper J.L., Buys S.S., Andrulis I.L., Senie R., Daly M.B., West D., Ostrander E.A., Offit K., Peretz T., Osorio A., Benitez J., Nathanson K.L., Sinilnikova O.M., Olah E., Bignon Y.J., Ruiz P., Badzioch M.D., Vasen H.F., Futreal A.P., Phelan C.M., Narod S.A., Lynch H.T., Ponder B.A., Eeles R.A., Meijers-Heijboer H., Stoppa-Lyonnet D., Couch F.J., Eccles D.M., Evans D.G.Chang-Claude J., Lenoir G., Weber B.L., Devilee P, Easton D.F., Goldgar D.E., Stratton M.R. (2002). From the Cover: Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proc Natl Acad Sci USA. 22;99(2):827-831.
Peretz T., Weshler Z., Goldberg Y., Durst A.L., Freund H.R.: (2000) Brief preoperative radiotherapy reduces local recurrences and improves survival in rectal cancer. Harefuah. 16: 138 (2), 96-99. (Hebrew).
Pikarski E., and Peretz T.(2000), Bone marrow metastases in breast cancer. N Eng J Med. 343: (8), 577-578,. (Letter).
Klein M., Weininger J., Moshe S., Peretz T., Chisin R: (2001). The use of external radioactive markers in scintimammography. Clinical Nuclear Medicine. 26: (1), 10-13.
Paltiel O., Avitzour T., Peretz T., Cherny N., Kadouri L., Pfeffer R.M., Wagner N., Soskolne V., (2001).Determinants of the use of complementary therapies by cancer patients. Journal of Clinical Oncology. 19: (9), 2439-2448.
Spira R.M., Peretz T., Hochner-Zelniker D., Freund H.R., (2001) Levonorgestrel – releasing IUD and breast cancer. Israel Medical Association Journal (IMAJ). 3: 711-711 (Letter).
Tanos V., Brzezinsky A., Drize O., Strauss N., Peretz T.,( 2002). Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro. Eur J Obstet Gynecol Reprod Biol. 102: (2), 188-194.
Psycho-Oncology
Baider L., Andritsch E, Goldzweig G, Uziely B, Ever-Hadani P, Hofman G, Krenn G, Samonigg H. (2004) Changes in psychological distress of women with breast cancer in long-term remission and their husbands. Psychosomatics. 45 (1): 58-68
Andritsch E, Goldzweig G, Samonigg H, Uziely B, Ever-Hadani P, Hofman G, Krenn G, Baider L. (2004) Changes in psychological distress of women in long-term remission from breast cancer in two different geographical settings: a randomized study. Support care cancer. 12(1): 10-8.
Baider L., Andritsch E, , Uziely B, Ever-Hadani P, Goldzweig G, Hofman G, Samonigg H. (2003) Do different cultural setting affect the psychological distress of women with breast cancer? A randomized study. Eur J Cancer Care 12(3): 263-73.
Baider L., Andritsch E, , Uziely B, Goldzweig G, Ever-Hadani P, Hofman G, Krenn G, Samonigg H. (2003) Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings. Crit Rev Oncol Hematol. 46(1):5-16. Review.
Baider L., Wein S., (2001) Reality and fugues in physicians facing death: confrontation, coping and adaptation at the bedside. Critical Reviews in Oncology-Hematology, 40:97-103.
Baider L., Bengel U., (2001) Cancer and the spouse:controversies on gender differentiation within health and illness. Critical Reviews in Onology-Hematology, 40:115-123.
Baider L., Holland J., Kaplan De-Nour A., (2001) The System of Belief Inventory (SBI-15R): A validation study in Israel. Psycho-Oncology, 10:534-541.
Baider L., Peretz T, Ever-Hadani P, Koch U: (2001) Psychological intervention in cancer patients: a randomized study. Gen Hosp Psychiatry. 23: (5) 272-277.
Lab of Radiobiology and Biotechnology
Vexler, A., Mou, X., Gabizon, A., Horowitz. and Gorodetsky, R. Reduction of the systemic toxicity of cisplatin by intra-arteial hepatic route administration for liver malignancies. Int J. Cancer 60: 611-615 (1995).
Gorodetsky, R., Vexler, A., Bar-Khaim, Y. and Biran, H. Plasma Pt. elimination in hemodialysis patient treated with cisplatin. Ther. Drug Monitor.17: 203-206 (1995).
Gorodetsky, R., Mou, X., Pfeffer, MR., Peretz, T., Levi Agababa, F. and Vexler, A. Subadditive effect of the combination of radiation and cisplatin in cultured murine and human cell lines Isr. J. Med. Sci. 31: 95-100 (1995).
Tirosh, O., Kohen, R., Katzhendler, Y., Gorodetsky, R. and Bernholtz, Y. Novel synthetic phospholipid protects lipid bilayers against oxidative damage: Role of hydration layer and bound water. J. Chem. Soc. Perk Tr 2 : 383-391 (1997).
Moyna, G., Williams, H.J., Scott, A.I., Ringel, I., Gorodetsky, R. & Swindell, C.S. Conformational studies of taxol analogs modified at the C-2' position in hydrophobic and hydrophilic solvent systems. J. Med. Chem., 40: 3305-3301 (1997).
Gorodetsky, R., Mou, X., Levi Agababa, F. and Vexler, A. In vitro studies on the combined effect of radiation with cisplatin. Int. J. Cancer. 75; 635-642 (1998).
Gorodetsky, R., Levdansky, L., Ringel I. and Vexler, A. Paclitaxel induced modification of the effects of radiation and alterations in the cell cycle in normal and tumore mammalian cells. Radiat. Res., 150: 283-291, (1998).
Gorodetsky, R., Vexler, A., An, J., Mou, X. and Marx, G. Chemotactic and Growth Stimulatory Effects of Fibrin(ogen) and thrombin on cultured fibroblasts J Lab Clin Med 131: 269-280 (1998).
Gorodetsky, R., Clark, RAF., Gailit, J., An, J., Vexler, A., Berman, E., Levdansky, L. and Marx, G. Fibrin microbeads as high density cell carriers for culturing and implanting cells, application for wound healing. J. Invet. Dermatol, 112; 866-873, (1999).
Enk, C.D., Elad, S., Vexler, A., Kapelushnik, J., Gorodetsky, R. and Kirschbaum, M. Chronic graft-versus-host disease treared with UVB phototherapy. BMT 22: 1179-1184 (1998).
Gorodetsky, R. And Vexler, A. Use of viscoelastic skin analyser (VESA) for non-invasive follow-up of late skin changes following radiotherapy in breast cancer International Forum on Wound Care, 1: 11-14, 1998.
Vexler, A., Polyansky, I. and Gorodetsky, R. Evaluation of skin Viscoelasticity and anisotropy bymeasurement of speed of shear wave propagation with viscoelasticity skin analyzer (VESA). J. Invest. Dermatol, 45: 893-900, 1999.
Gorodetsky R., An J., Vexler, A., Berman, E., Levdansky, L., and Marx, G. Fibrin microbeads (FMB) as biodegradable carriers for culturing cells. Skin Res. Technology, 5: 113, 1999.
Gorodetsky, R., Polyansky, I., Lotan, Ch., Piggot, K., Dische, S., Sounders, M., Pierce, L., Lichter, A. and Vexler, A. Late effects of dose fractionation on the mechanical properties of breast skin following post-lumpectomy radiotherapy. Int. J. Radiat. Oncol. Biol. Physics 45: 893-900, 1999.
Gorodetsky, R., Andriessen A., Lotan, Ch., Polyansky, I. Radiation-induced skin effects in breast cancer patients following radiotherapy and a possible radioprotective effect of Zn based cream. J Wound Care 8:514-519, 1999.
Richter, E., El-Sharif, N., Fischbein, A., Konijn, A., Gorodetsky, R., El-Sharif, H., Kaul, B., Hershko, C., Grauer, F., Foner, H., Al-Baba, A., Dweik, Z., Lihsounat, M. Re-emergence of lead poisoning from contaminated flour in a west bank Palestinian village Int J Occup Environ Health. 2000 Jul;6(3):183-6.
Gorodetsky, R., Vexler, A., An, J., Levdansky, L., Clark, RAF. and Marx, G. Fibrin microbeads (FMB) as biodegradable carriers for culturing cells and for accelerating wound healing. Jourmal des Plais et Cicatrisations, 26: 15-21, 2001.
Gurevitz, O., Vexler, A., Marx, G., Bar-Shavit, Z., Prigozhina, T., Levdansky, L., Slavin, S., and Gorodetsky, R. Fibrin microbeads for isolating and growing bone marrow-derived progenitor cells capable of forming bone tissue. Tissue Engineering, 8: 661-672, 2002.
Gorodetsky R., Vexler A., Shamir M., An J., Levdansky L., Shimeliovich I., Marx G. New cell attachment peptide sequences from conserved epitopes in the carboxy termini of fibrinogen. Exper. Cell Res. 2003; 287, 116-129.
Gerard Marx, Matti Ben-Moshe, Sholomo Magdassi, and Raphael Gorodetsky, Fibrinogen C-terminal peptidic sequences (Haptides) modulate fibrin polymerization. Thromb Haemost. 91:43-51, 2004.
Gorodetsky R, Levdansky L, Vexler A, Shimeliovich I, Kassis I, Ben-Moshe M, Magdassi S, Marx G. Liposome transduction into cells enhanced by haptotactic peptides (Haptides) homologous to fibrinogen C-chain termini. J Controlled Release 95 477-488, 2004.
Chapters in Books
Gorodetsky, R. and Withers, H.R. Assay of late radiation damage in mouse skin as expressed by wound healing. in: "Frontiers in Radiation Biology". Editor: E. Riklis. VCH and Balaban Publishers, pp 125-131 (1990).
Gorodetsky, R. A sensitive non-invasive analysis of trace elements in external tissues in clinical practice. In: "Trace Elements in Man and Animals", Editors: Anke M., D. Meissner C.F. Mills. Verlag Media Touristik Publishers., Germany, pp 75-80 (1993).
Gorodetsky, R., Vexler, A. and Marx, G. Fibrin Microbeads (FMB) for wound healing and tissue engineering of skin. In Cultured Human Keratinocytes and Tissue Engineered Skin Substitutes, RE Horch, MunsterAM & Achauer BM Editors, Georg Thieme Verlag, 2001
Gorodetsky, R. Vexler, A, Levdansky L. and Marx G.: Fibrin Microbeads (FMB) as biodegradable carriers for culturing cells and for accelerating wound healing. In Biopolymer Methods in Tissue Engineering, Editors A. Hollander and P. Hatton, p.11-23. Humana Press, 2004